These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10996460)

  • 21. Fibroblast growth factors enhance dopamine fiber formation from nigral grafts.
    Giacobini MM; Strömberg I; Almström S; Cao Y; Olson L
    Brain Res Dev Brain Res; 1993 Sep; 75(1):65-73. PubMed ID: 7693370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine embryonic EGF-responsive ventral mesencephalic neurospheres display distinct regional specification and promote survival of dopaminergic neurons.
    Moses D; Teper Y; Gantois I; Finkelstein DI; Horne MK; Drago J
    Exp Neurol; 2006 May; 199(1):209-21. PubMed ID: 16626706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons.
    Rideout HJ; Dietrich P; Savalle M; Dauer WT; Stefanis L
    J Neurochem; 2003 Feb; 84(4):803-13. PubMed ID: 12562524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia.
    Engele J; Bohn MC
    J Neurosci; 1991 Oct; 11(10):3070-8. PubMed ID: 1941074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system.
    Nosrat IV; Smith CA; Mullally P; Olson L; Nosrat CA
    Eur J Neurosci; 2004 May; 19(9):2388-98. PubMed ID: 15128393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of glial-derived dopaminergic growth factors by glucocorticoids and protein kinase C.
    Engele J; Lehner M
    Exp Neurol; 1995 May; 133(1):18-24. PubMed ID: 7601259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of dopaminergic neurons in the human mesencephalon and in vitro effects of basic fibroblast growth factor treatment.
    Silani V; Mariani D; Donato FM; Ghezzi C; Mazzucchelli F; Buscaglia M; Pardi G; Scarlato G
    Exp Neurol; 1994 Jul; 128(1):59-76. PubMed ID: 7915238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
    Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y
    Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a novel neurotrophic factor for dopaminergic neurons secreted from mesencephalic glial cell lines.
    Engele J; Rieck H; Choi-Lundberg D; Bohn MC
    J Neurosci Res; 1996 Mar; 43(5):576-86. PubMed ID: 8833092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture.
    Alexi T; Hefti F
    Neuroscience; 1993 Aug; 55(4):903-18. PubMed ID: 7901801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells.
    Apostolides C; Sanford E; Hong M; Mendez I
    Neuroscience; 1998 Mar; 83(2):363-72. PubMed ID: 9460746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line.
    Meyer M; Johansen J; Gramsbergen JB; Johansen TE; Zimmer J
    Exp Neurol; 2000 Jul; 164(1):82-93. PubMed ID: 10877918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity.
    Krieglstein K; Unsicker K
    Neuroscience; 1994 Dec; 63(4):1189-96. PubMed ID: 7700516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1).
    Iwakura Y; Zheng Y; Sibilia M; Abe Y; Piao YS; Yokomaku D; Wang R; Ishizuka Y; Takei N; Nawa H
    J Neurochem; 2011 Jul; 118(1):45-56. PubMed ID: 21517852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro.
    Eggert K; Schlegel J; Oertel W; Würz C; Krieg JC; Vedder H
    Neurosci Lett; 1999 Jul; 269(3):178-82. PubMed ID: 10454161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
    Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
    Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons.
    Chadi G; Cao Y; Pettersson RF; Fuxe K
    Neuroscience; 1994 Aug; 61(4):891-910. PubMed ID: 7838386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat.
    Blum M; Wu G; Mudó G; Belluardo N; Andersson K; Agnati LF; Fuxe K
    Neuroscience; 1996 Jan; 70(1):169-77. PubMed ID: 8848122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth factor-induced c-fos expression defines distinct subsets of midbrain dopaminergic neurons.
    Engele J; Schilling K
    Neuroscience; 1996 Jul; 73(2):397-406. PubMed ID: 8783257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo.
    Strelau J; Sullivan A; Böttner M; Lingor P; Falkenstein E; Suter-Crazzolara C; Galter D; Jaszai J; Krieglstein K; Unsicker K
    J Neurosci; 2000 Dec; 20(23):8597-603. PubMed ID: 11102463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.